Search
Filters
Clear All
  • 22
  • 61
  • 2
  • 680

Phase

  • 1
  • 17
  • 15
  • 52
  • 7
  • 72
  • 5
  • 587
  • 687
  • 300
  • 740
  • 25

Found 765 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

TROPICS

D
Daniel Cater
1 years - 17 years
All genders
Build decision support tools that can be used in future clinical trials to identify when children with septic shock should or should not be transfused with red blood cells. 
Learn More
Women Needed for Research Study on Strawberry, Immune Health, and Iron!

Women Needed for Research Study on Strawberry, Immune Health, and Iron!

S
Sixtus Aguree
18 years - 44 years
Accepts healthy volunteer
Female
What is this study about?The purpose of this study is to find out more about how the consumption of strawberry improves immune health and iron (a nutrient in the food we eat) status. This study compares effects of consuming strawberry powder (low vs high dose) on changes on markers of …
Check Eligibility

Caring for High-Risk Women with Congenital Heart Disease

C
Caroline Rouse, MD
16 years - 49 years
Female
The primary aim of this study is to evaluate patient knowledge regarding cardiovascular risk during pregnancy in people with CHD of reproductive age (16-49 years) following the passing of Indiana Senate Bill-1.Secondary outcomes include evaluation between perceived and actual cardiovascular risk of pregnancy in people with CHD and discrepancy between …
Learn More
Effect of CYP2B6 genotype and efavirenz on the disposition and pharmacodynamic of methadone and tizanidine in healthy volunteers

Effect of CYP2B6 genotype and efavirenz on the disposition and pharmacodynamic of methadone and tizanidine in healthy volunteers

Z
Zeruesenay Desta
18 years - 65 years
Accepts healthy volunteer
All genders
What is this study about?The purpose of this study is to see how efavirenz, a widely used medication to treat HIV infection, interacts with methadone (a medication used to treat addiction problems and pain) and tizanidine (a medication used to relax muscle) when taken at the same time.  The information learned …
Check Eligibility

Single Patient Use of ION-682884 for a Patient with Transthyretin Mediated Amyloid Cardiomyopathy

N
Noel Dasgupta
18 years - 100 years
All genders
 This study is being done to help potentially improve or stabilize heart failure related to transthyretin amyloidosis. The plan is to administer this investigational drug (ION-682884) 45 mg subcutaneously every 4 weeks.   
Learn More

Exhaled Breath Volatile Organic Compounds as Biomarkers for Pulmonary Exacerbation

M
Mike Davis
8 years - 60 years
Accepts healthy volunteer
All genders
We will obtain and measure exhaled VOCS in subjects with CF. We hypothesize that exhaled VOCs will differ between baseline and  PEx in subjects with CF. 
Learn More

Pilot trial to determine Relationship between Troponin Kinetics and Hemorrhagic MI

R
Rohan Dharmakumar
100 years or below
All genders
This study is a prospective, cohort study to determine the quantitative threshold differences in troponin-I level between hemorrhagic and non-hemorrhagic myocardial infarction (MI).
Learn More

Bone fragility determinants among children with T2D in comparison to healthy controls.

L
Linda DiMeglio, MD
5 years - 21 years
All genders
To define the prevalence of fracture among children with T1D and T2D and compare the prevalence among the two groups of diabetes.
Learn More

Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody (PROTECT Extension)

L
Linda DiMeglio, MD
8 years - 17 years
All genders
Phase 3
What is the purpose of this study?This study is the long-term extension of the PRV-031-001 (PROTECT) study. PROTECT is a Phase 3, randomized, double-blind, placebo-controlled, multinational, multi-center study to evaluate the efficacy and safety of teplizumab, a humanized, anti-CD3 monoclonal antibody, in children and adolescents ages 8 through 17 recently …
Learn More

ARDS in Children and ECMO initiation strategies impact on Neuro-Development (ASCEND)

M
Matthew Friedman, MD
14 years - 17 years
All genders
We will measure the neurodevelopmental impact incurred by children receiving usual care ECMO for PARDS.
Learn More
201 - 210 of 765